A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Loteprednol etabonate
Iofetamine I-123
The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Iofetamine I-123.
Loteprednol etabonate
Eluxadoline
The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Eluxadoline.
Loteprednol etabonate
Methylthioninium
The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Methylthioninium.
Loteprednol etabonate
Dextroamphetamine
The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Dextroamphetamine.
Loteprednol etabonate
Chlorphentermine
The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Chlorphentermine.
Loteprednol etabonate
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with 2,5-Dimethoxy-4-ethylamphetamine.
Loteprednol etabonate
Bezitramide
The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Bezitramide.
Loteprednol etabonate
Mephentermine
The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Mephentermine.
Loteprednol etabonate
Dexfenfluramine
The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with St. John's Wort.
Loteprednol etabonate
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with St. John's Wort.
Loteprednol etabonate
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with St. John's Wort.
Loteprednol etabonate
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with St. John's Wort.
Loteprednol etabonate
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with St. John's Wort.
Loteprednol etabonate
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with St. John's Wort.
Loteprednol etabonate
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with St. John's Wort.
Loteprednol etabonate
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with St. John's Wort.
Loteprednol etabonate
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with St. John's Wort.
Loteprednol etabonate
Cannabidiol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with St. John's Wort.
Loteprednol etabonate
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with St. John's Wort.
Loteprednol etabonate
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with St. John's Wort.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3